Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
March 17 2021 - 07:30AM
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused
on bioprocessing technology leadership, today announced that it
will present virtually at the KeyBanc Life Science and MedTech
Investor Forum being held March 23-24. Tony Hunt, President
& Chief Executive Officer, will participate in a fireside chat
on Wednesday, March 24, at 9:15 a.m. EDT.
A live webcast of the discussion will be accessible through
the Investor Relations section of the Company’s website, and
will be available for replay for a limited period of time following
the conference event.
About Repligen Corporation
Repligen Corporation is a global life sciences company that
develops and commercializes highly innovative bioprocessing
technologies and systems that increase efficiencies in the process
of manufacturing biological drugs. Our primary customers are
biopharmaceutical drug developers and contract development and
manufacturing organizations (CDMOs) worldwide. Our corporate
headquarters are located in Waltham, Massachusetts, with additional
administrative and manufacturing operations worldwide. The majority
of our manufacturing sites are located within the U.S. (California,
Massachusetts, New Jersey and New York), and outside of the U.S. we
have sites in Estonia, Germany, Ireland, the Netherlands and
Sweden.
Repligen Contact:Sondra S. NewmanGlobal Head of
Investor Relations(781) 419-1881investors@repligen.com
Repligen (NASDAQ:RGEN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Repligen (NASDAQ:RGEN)
Historical Stock Chart
From Mar 2023 to Mar 2024